How to Get Vyvanse in Indiana

Who Can Prescribe Vyvanse in Indiana

Any Indiana-licensed prescriber with DEA registration and Schedule II authority can write a Vyvanse prescription. That includes physicians (MDs and DOs), nurse practitioners, and physician assistants. Indiana law requires NPs to maintain a collaborative practice agreement with a physician, though the supervising physician does not need to see the patient directly.

Physicians (MD and DO)

Family medicine doctors, psychiatrists, and neurologists are the most common physician prescribers. A psychiatrist may be preferred for complex cases involving comorbid anxiety or mood disorders, but a primary care physician can initiate and manage Vyvanse for straightforward ADHD. Board-certified psychiatrists often have shorter wait times in metro areas like Indianapolis and Fort Wayne compared to rural counties.

Nurse Practitioners and Physician Assistants

Psychiatric-mental health nurse practitioners (PMHNPs) are increasingly the frontline prescribers for ADHD medications in Indiana. Under Indiana Code 25-23-1, NPs must operate under a collaborative agreement, but this does not restrict their ability to prescribe Schedule II drugs when the agreement includes that authority. PAs follow a similar model under their supervising physician's scope.

Telehealth Prescribers

Indiana permits telehealth prescribing of Schedule II stimulants. The Ryan Haight Act historically required an in-person exam before a controlled substance could be prescribed via telehealth. The DEA's temporary pandemic-era flexibilities, extended through 2025 and into 2026, allow an initial audio-video telehealth visit to satisfy this requirement [1]. Patients in rural Indiana counties where psychiatry wait times exceed 8 weeks often rely on telehealth platforms for faster access.

Steps to Getting a Vyvanse Prescription in Indiana

The path from first appointment to filled prescription typically takes 7 to 21 days when insurance is involved, though cash-pay patients can sometimes fill within 48 hours of evaluation.

Step 1: Schedule an Evaluation

Book an appointment with a licensed prescriber. You will need a diagnostic evaluation that documents ADHD symptoms using validated tools. The most commonly used instruments are the Adult ADHD Self-Report Scale (ASRS-v1.1) and the Conners' Adult ADHD Rating Scales. For children, the Vanderbilt Assessment Scale is standard. Wigal et al. Demonstrated in a 2017 study (N=336) that lisdexamfetamine produced statistically significant improvements in ADHD-RS-IV scores compared to placebo in both children and adolescents [2].

Step 2: Complete Required Labs

No specific lab work is required by the FDA before starting Vyvanse. However, most Indiana prescribers order baseline vitals (heart rate and blood pressure), and many request a basic metabolic panel and CBC to rule out conditions that mimic ADHD (thyroid dysfunction, anemia, electrolyte imbalances). Patients with a personal or family history of cardiac disease should expect an EKG. The FDA prescribing information for Vyvanse recommends monitoring heart rate and blood pressure at each visit [3].

Step 3: Obtain the Prescription

Because Vyvanse is Schedule II, the prescription must be written (paper or e-prescribed) and cannot be phoned or faxed to the pharmacy. Indiana permits electronic prescribing of controlled substances (EPCS), and most major pharmacy chains in the state accept EPCS. A prescriber may write up to a 90-day supply but cannot authorize refills on a single prescription. Each fill requires a new prescription.

Step 4: Fill at a Pharmacy

Take the prescription to any licensed Indiana pharmacy. CVS, Walgreens, Kroger, and Walmart pharmacies across the state stock brand-name Vyvanse. Generic lisdexamfetamine became available in August 2023 after Takeda's patent settlement allowed authorized generics [4]. Generic pricing is significantly lower, often $30 to $80 for a 30-day supply with a GoodRx-type discount card versus $350+ for brand-name without insurance.

Indiana Medicaid and Vyvanse Coverage

Indiana Medicaid (Hoosier Healthwise, Healthy Indiana Plan) does not include Vyvanse on its preferred drug list for ADHD or binge eating disorder. The state's Medicaid formulary limits coverage of brand-name stimulants when cheaper alternatives exist.

What Medicaid Covers Instead

Indiana Medicaid generally covers generic mixed amphetamine salts (Adderall), generic methylphenidate (Ritalin), and generic dextroamphetamine. Patients who fail two or more preferred agents may request a non-preferred prior authorization, but approval rates for Vyvanse through Indiana Medicaid remain low.

Commercial Insurance Options

Most commercial plans in Indiana (Anthem BCBS, UnitedHealthcare, Cigna, Aetna) cover Vyvanse with prior authorization. The prior authorization process typically requires documentation of: (1) a confirmed ADHD or BED diagnosis using DSM-5 criteria, (2) trial and failure of at least one preferred stimulant, and (3) the prescriber's rationale for selecting lisdexamfetamine. Turnaround time for PA decisions in Indiana averages 3 to 5 business days. An expedited or urgent PA can be processed within 24 hours.

Manufacturer Savings Programs

Takeda offers the Vyvanse Savings Card, which can reduce out-of-pocket costs to as low as $30 per month for commercially insured patients. Uninsured patients may qualify for Takeda's Help at Hand Patient Assistance Program, which provides Vyvanse at no cost to patients meeting income thresholds (generally below 250% of the federal poverty level). Application requires proof of income and a signed prescription from the treating provider.

Telehealth Access for Vyvanse in Indiana

Telehealth has become one of the fastest routes to a Vyvanse prescription in Indiana, particularly outside the Indianapolis metro area.

How Telehealth Prescribing Works

Indiana telehealth regulations, codified under Indiana Code 25-1-9.5, require that the provider be licensed in Indiana and that the encounter use real-time audio-video technology. Asynchronous (store-and-forward) evaluations are not sufficient for Schedule II prescriptions. The initial visit typically lasts 45 to 60 minutes and includes a structured diagnostic interview, symptom history, and review of prior medical records.

Choosing a Telehealth Provider

Look for providers who are Indiana-licensed, DEA-registered, and experienced with ADHD. Psychiatric-mental health nurse practitioners and board-certified psychiatrists are the most common telehealth ADHD prescribers. Some national telehealth platforms operate in Indiana, but patients should verify that the specific clinician holds an active Indiana license. The Indiana Professional Licensing Agency's online license verification tool can confirm any provider's credentials.

Follow-Up and Monitoring

After the initial prescription, follow-up visits are typically scheduled every 30 days for the first 3 months, then every 90 days once the dose is stable. The American Academy of Pediatrics recommends titrating to the lowest effective dose and monitoring for cardiovascular effects, appetite suppression, and sleep disruption [5]. Telehealth follow-ups generally last 15 to 20 minutes.

Pharmacy Options in Indiana

Indiana patients have access to retail chains, independent pharmacies, and 503A compounding pharmacies.

Retail and Chain Pharmacies

Every major chain (CVS, Walgreens, Walmart, Kroger) fills lisdexamfetamine prescriptions. Stock availability varies. Schedule II medications can experience periodic supply disruptions due to DEA manufacturing quotas. If your regular pharmacy is out of stock, Indiana law allows you to transfer your unfilled prescription to another pharmacy. Call ahead to confirm availability before driving.

503A Compounding Pharmacies

Licensed 503A compounding pharmacies in Indiana may compound lisdexamfetamine into alternative forms (such as a liquid suspension) for patients who cannot swallow capsules. This requires a patient-specific prescription. Compounded medications are not AB-rated generics, meaning they have not undergone FDA bioequivalence testing. The Indiana Board of Pharmacy oversees 503A facilities under 856 IAC 1-35.

Mail-Order Pharmacy

Some commercial insurance plans require or incentivize 90-day fills through mail-order pharmacies like Express Scripts, OptumRx, or CVS Caremark. For Schedule II substances, the prescriber must send a separate prescription for each 90-day fill. Mail-order can reduce per-unit cost and eliminates monthly pharmacy trips, but initial processing takes 7 to 14 days.

Prior Authorization: What Indiana Patients Need to Know

Prior authorization is the single biggest barrier between an Indiana patient and their Vyvanse prescription. Understanding the process cuts weeks off the timeline.

Documents Your Prescriber Will Need

The insurance company will request: a letter of medical necessity, the DSM-5 diagnostic code (F90.0 for predominantly inattentive, F90.1 for predominantly hyperactive-impulsive, or F90.2 for combined type), records of previous medication trials (drug name, dose, duration, reason for discontinuation), and any relevant psychological testing results.

Step Therapy Requirements

Most Indiana commercial plans impose step therapy. This means the patient must try and fail a generic stimulant before the plan approves Vyvanse. "Failure" can mean inadequate symptom control at adequate doses, intolerable side effects, or a documented contraindication. A 2019 review in the Journal of Managed Care & Specialty Pharmacy found that step therapy for ADHD medications delayed appropriate treatment by an average of 14.6 days [6].

Appeals Process

If a PA is denied, Indiana patients have the right to appeal. The first-level appeal goes back to the insurance company's pharmacy benefit manager. If that fails, Indiana law provides for an external review through the Indiana Department of Insurance. The external review must be completed within 45 days of the request.

Transferring a Vyvanse Prescription to Indiana

Patients relocating to Indiana from another state face specific rules for Schedule II transfers.

From Another State

A Vyvanse prescription written by an out-of-state prescriber can be filled at an Indiana pharmacy as long as the prescription is valid under the originating state's law and the Indiana pharmacy can verify the prescriber's credentials. However, most Indiana pharmacies prefer to see an Indiana-licensed prescriber on the script, especially for controlled substances. The practical solution: establish care with an Indiana provider (in-person or telehealth) and bring records from your previous prescriber.

Within Indiana

Transferring an unfilled Schedule II prescription between Indiana pharmacies is permitted. The original pharmacy voids the prescription and sends it to the receiving pharmacy. Partially filled Schedule II prescriptions cannot be transferred under federal law.

Cost of Vyvanse in Indiana Without Insurance

Brand-name Vyvanse without insurance runs $350 to $450 for a 30-day supply at most Indiana retail pharmacies. Generic lisdexamfetamine is substantially cheaper.

Strategies to Reduce Cost

Discount cards from GoodRx, RxSaver, or SingleCare can bring generic lisdexamfetamine below $50 at some Indiana Walmart and Kroger locations. Takeda's patient assistance program covers uninsured patients below the income threshold. Some patients also find savings through Mark Cuban's Cost Plus Drugs, which lists generic lisdexamfetamine at near-wholesale pricing plus a flat dispensing fee. Comparing prices across at least three pharmacies before filling can save $20 to $100 per month.

Safety Monitoring on Vyvanse

Lisdexamfetamine is a prodrug that converts to dextroamphetamine after absorption. It carries the same cardiovascular and psychiatric monitoring requirements as other amphetamine-class stimulants.

Cardiovascular Monitoring

The FDA label warns against use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or coronary artery disease [3]. Baseline and periodic blood pressure and heart rate monitoring are required. A meta-analysis published in The Lancet Psychiatry (Cortese et al., 2018, N=10,068 across 133 trials) found that stimulant medications were associated with small but statistically significant increases in systolic blood pressure (mean +1.2 mmHg) and heart rate (mean +5.7 bpm) [7].

Psychiatric Monitoring

Prescribers should screen for comorbid anxiety, bipolar disorder, and tic disorders before initiating Vyvanse. Stimulants can exacerbate these conditions. The prescribing information notes reports of treatment-emergent psychotic or manic symptoms in patients without prior history [3].

Abuse and Diversion Risk

As a Schedule II substance, lisdexamfetamine carries abuse potential, though its prodrug mechanism provides a slower onset than immediate-release amphetamine formulations. Jasinski and Krishnan (2009) demonstrated in a human abuse liability study (N=36) that lisdexamfetamine produced lower subjective "Drug Liking" scores compared to equivalent doses of immediate-release d-amphetamine [8].